Total Payments
$12,260
2024 Payments
$2,248
Companies
64
Transactions
740
Medicare Patients
3,298
Medicare Billing
$422,202
Payment Breakdown by Category
Food & Beverage$12,086 (98.6%)
Education$94.32 (0.8%)
Other$79.73 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,086 | 728 | 98.6% |
| Education | $94.32 | 7 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79.73 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,152 | 92 | $0 (2024) |
| ABBVIE INC. | $914.75 | 57 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $785.31 | 45 | $0 (2023) |
| Amgen Inc. | $521.00 | 24 | $0 (2023) |
| Mallinckrodt LLC | $480.52 | 26 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $464.27 | 20 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $443.79 | 33 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $441.56 | 37 | $0 (2022) |
| Lilly USA, LLC | $409.35 | 23 | $0 (2024) |
| PFIZER INC. | $407.45 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,248 | 127 | ABBVIE INC. ($253.64) |
| 2023 | $1,910 | 114 | Lilly USA, LLC ($182.96) |
| 2022 | $1,488 | 78 | ABBVIE INC. ($310.94) |
| 2021 | $1,010 | 58 | AbbVie Inc. ($147.08) |
| 2020 | $239.94 | 14 | Sunovion Pharmaceuticals Inc. ($37.08) |
| 2019 | $1,013 | 63 | Allergan Inc. ($137.42) |
| 2018 | $2,340 | 141 | Novartis Pharmaceuticals Corporation ($349.58) |
| 2017 | $2,011 | 145 | UCB, Inc. ($264.60) |
All Payment Transactions
740 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.05 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.60 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Rare Disease | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.67 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.03 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.89 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Rare Disease | ||||||
| 10/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,266 | 9,074 | $522,541 | $169,989 |
| 2022 | 18 | 814 | 5,254 | $286,325 | $89,226 |
| 2021 | 20 | 688 | 4,318 | $243,125 | $91,117 |
| 2020 | 14 | 530 | 3,336 | $206,145 | $71,870 |
Total Patients
3,298
Total Services
21,982
Medicare Billing
$422,202
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96133 | Evaluation of neuropsychological test, each additional hour | Office | 2023 | 64 | 448 | $109,760 | $34,103 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 258 | 425 | $85,000 | $27,038 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 144 | 144 | $49,680 | $16,539 | 33.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 59 | 139 | $29,885 | $10,300 | 34.5% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 57 | 60 | $31,500 | $10,039 | 31.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 31 | 31 | $23,250 | $8,745 | 37.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 47 | 47 | $21,150 | $7,214 | 34.1% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 66 | 67 | $20,100 | $6,442 | 32.0% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 64 | 64 | $18,240 | $6,431 | 35.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 34 | 35 | $14,000 | $4,707 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 48 | $13,200 | $4,334 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 31 | $11,625 | $4,141 | 35.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 12 | 12 | $10,800 | $3,639 | 33.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 20 | 21 | $9,975 | $3,373 | 33.8% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 25 | 25 | $10,750 | $3,074 | 28.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 14 | 14 | $8,610 | $3,000 | 34.8% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 34 | 196 | $11,760 | $2,771 | 23.6% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 65 | 75 | $4,875 | $2,194 | 45.0% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 22 | 22 | $6,600 | $2,160 | 32.7% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2023 | 13 | 13 | $6,825 | $2,143 | 31.4% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 33 | 102 | $7,650 | $2,094 | 27.4% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 18 | 18 | $5,400 | $1,777 | 32.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $5,060 | $1,553 | 30.7% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 13 | 13 | $2,535 | $878.64 | 34.7% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 64 | 6,980 | $1,396 | $758.62 | 54.3% |
About Dr. Brian Rabin, M.D
Dr. Brian Rabin, M.D is a Neurology healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1386898419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Rabin, M.D has received a total of $12,260 in payments from pharmaceutical and medical device companies, with $2,248 received in 2024. These payments were reported across 740 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($12,086).
As a Medicare-enrolled provider, Rabin has provided services to 3,298 Medicare beneficiaries, totaling 21,982 services with total Medicare billing of $422,202. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurological Surgery, Student in an Organized Health Care Education/Training Program
- Location Chandler, AZ
- Active Since 11/17/2008
- Last Updated 11/04/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1386898419
Products in Payments
- Briviact (Drug) $814.38
- ACTHAR (Biological) $560.54
- APTIOM (Drug) $504.28
- NURTEC ODT (Drug) $438.11
- Aimovig (Biological) $433.39
- NUPLAZID (Drug) $421.47
- QULIPTA (Drug) $382.81
- BOTOX (Biological) $373.10
- UBRELVY (Drug) $342.31
- TROKENDI XR (Drug) $325.28
- Rebif (Biological) $291.05
- VYVGART HYTRULO (Drug) $285.18
- OCREVUS (Biological) $284.46
- GILENYA (Drug) $281.11
- AUBAGIO (Drug) $268.69
- AIMOVIG (Biological) $261.93
- Neupro (Drug) $241.77
- ZEPOSIA (Drug) $239.60
- EMGALITY (Drug) $224.13
- Xyrem (Drug) $220.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Chandler
Dr. Andrea An, Md, MD
Neurology — Payments: $18,246
Neurology $18,246
Charanjit Dhillon, Md, MD
Neurology — Payments: $14,998
Neurology $14,998
Dr. Mohamed Elkotb, M.d, M.D
Neurology — Payments: $1,046
Neurology $1,046
Rama Narasimhan, Md, MD
Neurology — Payments: $677.34
Neurology $677.34
Nicole Salvatore, Pa-C, PA-C
Neurology — Payments: $25.70
Neurology $25.70
Mrs. Haylie Leighton, Pt, Dpt, PT, DPT
Neurology
Neurology